Your browser doesn't support javascript.
loading
[18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer.
Sharma, Rohini; Valls, Pablo Oriol; Inglese, Marianna; Dubash, Suraiya; Chen, Michelle; Gabra, Hani; Montes, Ana; Challapalli, Amarnath; Arshad, Mubarik; Tharakan, George; Chambers, Ed; Cole, Tom; Lozano-Kuehne, Jingky P; Barwick, Tara D; Aboagye, Eric O.
Afiliação
  • Sharma R; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0HS, UK. r.sharma@imperial.ac.uk.
  • Valls PO; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0HS, UK.
  • Inglese M; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0HS, UK.
  • Dubash S; Department of Computer, Control and Management Engineering Antonio Ruberti, University of Rome "La Sapienza", Rome, Italy.
  • Chen M; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0HS, UK.
  • Gabra H; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0HS, UK.
  • Montes A; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0HS, UK.
  • Challapalli A; Clinical Discovery Unit, Early Clinical Development, AstraZeneca, Cambridge, UK.
  • Arshad M; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Tharakan G; Bristol Cancer Institute, UH Bristol NHS Foundation Trust, Bristol, UK.
  • Chambers E; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0HS, UK.
  • Cole T; Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK.
  • Lozano-Kuehne JP; Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK.
  • Barwick TD; Department of Medicine, Division of Experimental Medicine, NIHR Imperial Clinical Research Facility, Imperial College London, London, UK.
  • Aboagye EO; Department of Surgery and Cancer, Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0HS, UK.
Eur J Nucl Med Mol Imaging ; 47(5): 1239-1251, 2020 05.
Article em En | MEDLINE | ID: mdl-31754793
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Paclitaxel Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Paclitaxel Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article